ANTIBIOTICE IASI
78 articole · RSS
Antibiotice And Biofarm, Among Most Profitable Stock Investments
The shares of drug producers Antibiotice Iasi (ATB.RO) and Biofarm Bucuresti (BIO.RO) generated over 50% profits in the past year, including the dividends paid to shareholders, which makes t...
Ioan Nani: Antibiotice Iasi Can Grow Into A Regional Player With Help From An Investor
Romania’s state-run drugmaker Antibiotice Iasi can grow to become a player in the region, but with support from an investor and improved legislation, the company’s general manager Ioan Nani...
Antibiotice Iasi 1H Sales Down 4% To RON142M
Sales of Romanian state-run drug maker Antibiotice Iasi (ATB.RO) declined 4% in the first half of the year, to RON141.8 million (EUR32.3 million), and its net profit dropped 37%, to RON16.1...
Antibiotice Takes EUR11.3M Credit Line For Working Capital
Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) took two credit lines of EUR9.5 million and 8 million lei (EUR1.8 million) to finance its working capital, the company said in a statem...
Antibiotice Proposes RON17.2M Share Capital Hike
The managing board of Romanian state-owned medicine maker Antibiotice Iasi (ATB.RO) increased to 17.2 million lei (EUR3.9 million) the sum proposed to stockholders as share capital hike, acc...
Antibiotice To Sell Medicine Worth RON68M Through Pharma Iasi
Romanian medicine maker Antibiotice Iasi (ATB.RO) on Tuesday corrected to 68 million lei (EUR16 million), from RON50 million, the value of the medicine sale contract inked with wholesaler Ph...